M A Borg
Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals
Borg, M A; Zerafa, R; Morrison, Donald; Cuschieri, P
Abstract
The incidence of hetero-intermediate glycopeptide
susceptibility among Staphylococcus aureus
isolates in Malta, a country with a high incidence
of methicillin resistance, was studied by screening
454 non-repetitive S. aureus isolates on teicoplanin-
supplemented agar plates, followed by Etests
and genotypic studies. All strains were susceptible
to vancomycin, but four (0.88%) exhibited
teicoplanin MICs of > 12 mg⁄ L. High methicillinresistant
S. aureus endemicity was not an accurate
predictor of the emergence of non-susceptibility
to glycopeptides.
Citation
Borg, M. A., Zerafa, R., Morrison, D., & Cuschieri, P. (2005). Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals. Clinical Microbiology and Infection, 11(5), 405-407. https://doi.org/10.1111/j.1469-0691.2005.01110.x
Journal Article Type | Article |
---|---|
Publication Date | 2005-05 |
Deposit Date | Jun 12, 2015 |
Print ISSN | 1198-743X |
Electronic ISSN | 1469-0691 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 11 |
Issue | 5 |
Pages | 405-407 |
DOI | https://doi.org/10.1111/j.1469-0691.2005.01110.x |
Keywords | h-GISA; Malta; resistance, Staphylococcus aureus; teicoplanin; vancomycin; |
Public URL | http://researchrepository.napier.ac.uk/id/eprint/8678 |
Publisher URL | http://dx.doi.org/10.1111/j.1469-0691.2005.01110.x |